Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
-
1261
The characteristics of 52 studies included in the systematic review and meta-analysis.
Published 2024Subjects: -
1262
Quality assessment scores for 42 studies across each item of the three domains.
Published 2024Subjects: -
1263
-
1264
Aggregated population-level ecological factors associated with TB incidence.
Published 2024Subjects: -
1265
-
1266
-
1267
Forest plot of pooled effects of ecological factors associated with TB incidence.
Published 2024Subjects: -
1268
-
1269
-
1270
Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database.
Published 2025Subjects: -
1271
Image 4_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.tif
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1272
Image 3_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.tif
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1273
Table 1_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.xlsx
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1274
Image 1_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.tif
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1275
Table 3_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.xlsx
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1276
Table 4_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.xlsx
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1277
Table 2_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.xlsx
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1278
Image 2_Identification of three T cell-related genes as diagnostic and prognostic biomarkers for triple-negative breast cancer and exploration of potential mechanisms.tif
Published 2025“…Background<p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BRCA) with limited therapeutic targets. …”
-
1279
Image 1_Androgen receptor activation promotes tumor progression in canine and human triple negative breast cancer cell lines.tif
Published 2025“…Introduction<p>Triple negative breast cancer (TNBC) is an aggressive type of breast cancer that lack of expression of hormonal receptors and HER-2 that limits the approach of effective therapies. …”
-
1280
Data Sheet 1_Integration of chromosome conformation and gene expression networks reveals regulatory mechanisms in triple negative breast cancer.zip
Published 2025“…Introduction<p>Triple-negative breast cancer (TNBC) accounts for twelve percent of all breast cancer cases, with a survival rate around ten percent lower than ER+/PR+ positive breast cancers. …”